In this Coffee and Conversation, Elizabeth Jennings will share how 2020 has reshaped thinking around early stage investing--and how innovative businesses can use this to their advantage. Especially pertinent to healthcare and cleantech, we'll walk through techniques for developing a resilient commercial narrative and strategy to move forward conversations with both investors and partners alike amid the relative uncertainty of 2021. You'll learn how to reframe your go-to-market strategy to align with fund theses and strategies, tactics for getting useful feedback from key players, and early steps you can take to improve your leverage.

Elizabeth aims to maximize the impact of for-good startups. She speaks frequently on investment and innovation within regulated industries, serves as an advisor to several medical device, in-vitro diagnostics, and AI startups.